Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2005 1
2006 1
2007 3
2008 4
2009 3
2010 2
2011 1
2012 5
2013 6
2014 2
2015 2
2016 9
2017 4
2018 12
2019 8
2020 10
2021 10
2022 13
2023 10
2024 10
2025 6
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
The complement system and human autoimmune diseases.
Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP, Yu CY. Coss SL, et al. Among authors: ardoin sp. J Autoimmun. 2023 May;137:102979. doi: 10.1016/j.jaut.2022.102979. Epub 2022 Dec 18. J Autoimmun. 2023. PMID: 36535812 Free PMC article. Review.
CAR T cell therapy for children with rheumatic disease: the time is now.
Wobma H, Ardoin SP, Bonifant CL, Cooper JC, Kim H, Sadun RE, Lewandowski L, Keller M, Colbert RA, Edens C, DeQuattro K, Driest K, Shalen J, Stojkic I, Knight A, Annesley C, Torok KS, Elgarten CW, Onishi T, Jackson SW, Prockop S, Shah NN, Ardalan K, Lamb M; Integrated Multidisciplinary Paediatric Autoimmunity and Cell Therapy (IMPACT) working group*. Wobma H, et al. Among authors: ardoin sp. Nat Rev Rheumatol. 2025 Aug;21(8):494-506. doi: 10.1038/s41584-025-01272-3. Epub 2025 Jul 2. Nat Rev Rheumatol. 2025. PMID: 40603629 Free PMC article. Review.
Outcome Measures in Pediatric Rheumatic Disease.
Ringold S, Consolaro A, Ardoin SP. Ringold S, et al. Among authors: ardoin sp. Rheum Dis Clin North Am. 2021 Nov;47(4):655-668. doi: 10.1016/j.rdc.2021.07.013. Rheum Dis Clin North Am. 2021. PMID: 34635297 Review.
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
Chalhoub NE, Wenderfer SE, Levy DM, Rouster-Stevens K, Aggarwal A, Savani SI, Ruth NM, Arkachaisri T, Qiu T, Merritt A, Onel K, Goilav B, Khubchandani RP, Deng J, Fonseca AR, Ardoin SP, Ciurtin C, Kasapcopur O, Jelusic M, Huber AM, Ozen S, Klein-Gitelman MS, Appenzeller S, Cavalcanti A, Fotis L, Lim SC, Silva RM, Miramontes JR, Rosenwasser NL, Saad-Magalhaes C, Schonenberg-Meinema D, Scott C, Silva CA, Enciso S, Terreri MT, Torres-Jimenez AR, Trachana M, Al-Mayouf SM, Devarajan P, Huang B, Brunner HI; Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party. Chalhoub NE, et al. Among authors: ardoin sp. Arthritis Rheumatol. 2022 Feb;74(2):263-273. doi: 10.1002/art.41930. Epub 2022 Jan 4. Arthritis Rheumatol. 2022. PMID: 34279063 Free PMC article.
The pediatric glucocorticoid toxicity index.
Brogan P, Naden R, Ardoin SP, Cooper JC, De Benedetti F, Dicaire JF, Eleftheriou D, Feldman B, Goldin J, Karol SE, Price-Kuehne F, Skuse D, Stratakis CA, Webb N, Stone JH. Brogan P, et al. Among authors: ardoin sp. Semin Arthritis Rheum. 2022 Oct;56:152068. doi: 10.1016/j.semarthrit.2022.152068. Epub 2022 Jul 14. Semin Arthritis Rheum. 2022. PMID: 35917759 Free article.
Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach.
Cross H, Peng J, McDonnell T, Goulden B, Cheema F, Tan A, Parker J, Adeyeye R, Ardoin SP, Schanberg LE, Lewandowski LB; APPLE trial investigators and Childhood Arthritis and Rheumatology Research Alliance (CARRA); Ciurtin C, Robinson GA. Cross H, et al. Among authors: ardoin sp. Ann Rheum Dis. 2026 Jun;85(6):1125-1139. doi: 10.1016/j.ard.2025.12.011. Epub 2026 Jan 14. Ann Rheum Dis. 2026. PMID: 41539892 Free article.
Multicenter randomized controlled trial of cognitive-behavioral, exercise-based, and combined interventions for juvenile fibromyalgia.
Kashikar-Zuck S, Williams SE, Ittenbach RF, Peugh J, Thomas S, Lynch-Jordan AM, Kirschman M, Ting TV, Connelly M, Zempsky W, Williams AE, Ardoin SP, Logan DE, Wakefield EO, Goldstein-Leever A, Goldschneider K, Nelson S, Stinson JN, Myer GD. Kashikar-Zuck S, et al. Among authors: ardoin sp. Pain. 2026 Apr 1;167(4):820-831. doi: 10.1097/j.pain.0000000000003840. Epub 2025 Nov 21. Pain. 2026. PMID: 41852282 Clinical Trial.
Complement inhibitor for therapy of CHAPLE.
Yu CY, Ardoin SP. Yu CY, et al. Among authors: ardoin sp. Nat Immunol. 2021 Feb;22(2):106-108. doi: 10.1038/s41590-020-00842-9. Nat Immunol. 2021. PMID: 33398184 Free PMC article. No abstract available.
Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis.
Wang CS, Sadun RE, Zhou W, Miller KR, Ardoin SP, Bearer C, Hause E, Hui-Yuen J, Ling N, Pereira M, Riebschleger M, Rouster-Stevens K, Sarkissian A, Shalen J, Soulsby WD, Twilt M, Wu EY, Lewandowski LB, Wenderfer SE, Cooper JC; Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Working Group. Wang CS, et al. Among authors: ardoin sp. ACR Open Rheumatol. 2025 Dec;7(12):e70132. doi: 10.1002/acr2.70132. ACR Open Rheumatol. 2025. PMID: 41294283 Free PMC article.
115 results